Concepedia

Yoshiyuki Iwatsuki

YI

Statistics

Publications

11

Citations

365

H-Index

11

Active since

2004

Affiliations

Astellas Pharma (Japan)(Current)

Yoshiyuki Iwatsuki is an author at Astellas Pharma (Japan) specializing in pharmacology, drug discovery, and pharmacy.

Publications per year

2004–2014

11

Publications

11

AKR‐501 (YM477) a novel orally‐active thrombopoietin receptor agonist

Mari Fukushima‐Shintani, Kenichi Suzuki, Yoshiyuki Iwatsuki et al. · European Journal Of Haematology · 2008 · 80 citations

, , +11

AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis

Mari Fukushima‐Shintani, Kenichi Suzuki, Yoshiyuki Iwatsuki et al. · Experimental Hematology · 2008 · 62 citations

, , +10

Renoprotective properties of pirfenidone in subtotally nephrectomized rats

Koji Takakuta, Akira Fujimori, Toshihiro Chikanishi et al. · European Journal of Pharmacology · 2009 · 50 citations

, , +9

Biochemical and pharmacological profile of darexaban, an oral direct factor Xa inhibitor

Yoshiyuki Iwatsuki, Takayuki Sato, Yumiko Moritani et al. · European Journal of Pharmacology · 2011 · 38 citations

, , +10

Discovery of <i>N</i> -[2-Hydroxy-6-(4-methoxybenzamido)phenyl]-4- (4-methyl-1,4-diazepan-1-yl)benzamide (Darexaban, YM150) as a Potent and Orally Available Factor Xa Inhibitor

Fukushi Hirayama, Hiroyuki Koshio, Tsukasa Ishihara et al. · Journal of Medicinal Chemistry · 2011 · 35 citations · Full text

, , +17

1–5 of 11